Novel Double-Antigen Sandwich Immunoassay for Human Hepatitis B Core Antibody

ABSTRACT A novel diagnostic immunoassay testing procedure for hepatitis B virus core antibody (anti-HBc) using homogeneous purified full-length hepatitis B virus core antigen (HBcAg) capsids obtained from Escherichia coli was compared with Abbott Architect anti-HBc chemiluminescent microparticle immunoassay (CMIA; indirect method) against a library of specimens. A monoclonal anti-HBc neutralization confirmatory assay was then used to determine the degree of discordance between specimens. The new assay was found to be superior in both sensitivity and specificity.

[1]  A. Ocampo,et al.  Clinical significance of "anti-HBc alone" in human immunodeficiency virus-positive patients. , 2009, World journal of gastroenterology.

[2]  A. Doglio,et al.  Detection of antibodies to hepatitis B core antigen using the Abbott ARCHITECT anti-HBc assay: analysis of borderline reactive sera. , 2008, Journal of virological methods.

[3]  V. Meli,et al.  Can the serological status of “anti‐HBc alone” be considered a sentinel marker for detection of “occult” HBV infection? , 2008, Journal of medical virology.

[4]  S. Ramia,et al.  Hepatitis B virus DNA in serum of 'anti-HBc only'-positive healthy Lebanese blood donors: significance and possible implications. , 2007, The Journal of hospital infection.

[5]  A. Hartmann,et al.  Serological pattern "anti-HBc alone": characterization of 552 individuals and clinical significance. , 2006, World journal of gastroenterology.

[6]  H. Tillmann,et al.  Isolated anti-HBV core phenotype in anti-HCV-positive patients is associated with hepatitis C virus replication. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  F. Suk,et al.  Stability and Morphology Comparisons of Self-AssembledVirus-Like Particles from Wild-Type and Mutant Human Hepatitis B VirusCapsidProteins , 2003, Journal of Virology.

[8]  G. Colucci,et al.  Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. , 2003, Journal of hepatology.

[9]  T. Sallam,et al.  The significance of 'anti-HBc only' in the clinical virology laboratory. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[10]  S. Glynn,et al.  Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti‐HBc: implications for transfusion transmission and donor screening , 2003, Transfusion.

[11]  H. Doerr,et al.  Hepatitis B virus markers in anti‐HBc only positive individuals * , 2001, Journal of medical virology.

[12]  I. Dervite,et al.  Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. , 2001, The New England journal of medicine.

[13]  H. Margolis,et al.  Serological pattern “anti‐HBc alone”: Report on a workshop , 2000, Journal of medical virology.

[14]  W. Jilg,et al.  High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. , 2000, The Journal of general virology.

[15]  G. Martorana,et al.  The long‐term course of chronic hepatitis B , 1999, Hepatology.

[16]  L. Gordon,et al.  Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  C. Rieux,et al.  Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc. , 1998, Transplantation.

[18]  P. Wingfield,et al.  Hepatitis core antigen produced in Escherichia coli: subunit composition, conformational analysis, and in vitro capsid assembly. , 1995, Biochemistry.

[19]  P. Grob,et al.  Detection of HBs antigen in "anti-HBc alone" positive sera. , 1994, Journal of hepatology.

[20]  J. Phillips,et al.  Stability of the recombinant hepatitis B core antigen , 1992, Journal of clinical microbiology.

[21]  F. Schödel,et al.  The structure of hepadnaviral core antigens. Identification of free thiols and determination of the disulfide bonding pattern. , 1992, The Journal of biological chemistry.

[22]  P. Holland,et al.  Characterization of a reduction-sensitive factor from human plasma responsible for apparent false activity in competitive assays for antibody to hepatitis B core antigen , 1991, Journal of clinical microbiology.

[23]  E. F. Robertson,et al.  Improvement in the specificity of assays for detection of antibody to hepatitis B core antigen , 1991, Journal of clinical microbiology.

[24]  H. Beyer,et al.  Unsatisfactory specificities and sensitivities of six enzyme immunoassays for antibodies to hepatitis B core antigen , 1989, Journal of clinical microbiology.

[25]  M. Sällberg,et al.  Enzyme immunoassay for anti-hepatitis B core (HBc) immunoglobulin G1 and significance of low-level results in competitive assays for anti-HBc , 1989, Journal of clinical microbiology.

[26]  R. Luzzati,et al.  CLINICAL REACTIVATION OF HEPATITIS B IN ANTI-HBs-POSITIVE PATIENTS WITH AIDS , 1989, The Lancet.

[27]  G. Dusheiko,et al.  Natural History of Hepatitis B Virus Infection in Renal Transplant Recipients–A Fifteen‐Year Follow‐Up , 2007, Hepatology.

[28]  J. Wands,et al.  Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. , 1975, Gastroenterology.